These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10049452)

  • 1. Economic impact of surveillance.
    Ransohoff DF
    Gastrointest Endosc; 1999 Mar; 49(3 Pt 2):S67-71. PubMed ID: 10049452
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of the low-risk malignant polyp: is watchful waiting the best option?
    Kennedy E
    Dis Colon Rectum; 2010 Feb; 53(2):113-4. PubMed ID: 20087083
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for large bowel cancer.
    Barnes R
    Practitioner; 1989 May; 233(1468):691-4. PubMed ID: 2513566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of endoscopy in the prevention of digestive cancer: application to colorectal cancer.
    Lambert R
    Endoscopy; 1998 Sep; 30(7):628-40. PubMed ID: 9826143
    [No Abstract]   [Full Text] [Related]  

  • 5. Occult blood screening of Canadians: wise or unwise?
    Simon JB
    CMAJ; 1985 Oct; 133(7):647-9. PubMed ID: 4042034
    [No Abstract]   [Full Text] [Related]  

  • 6. Small and diminutive polyps detected at screening CT colonography: a decision analysis for referral to colonoscopy.
    Pickhardt PJ; Hassan C; Laghi A; Zullo A; Kim DH; Iafrate F; Morini S
    AJR Am J Roentgenol; 2008 Jan; 190(1):136-44. PubMed ID: 18094303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic implications of radiologic screening for colonic cancer.
    Gelfand DW; Ott DJ
    AJR Am J Roentgenol; 1991 May; 156(5):939-43. PubMed ID: 1902013
    [No Abstract]   [Full Text] [Related]  

  • 8. Follow-up colonoscopy in patients with colorectal adenomatous polyps.
    Nava H; Carlsson G; Petrelli NJ; Mittelman A
    Prog Clin Biol Res; 1988; 279():79-87. PubMed ID: 3186775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary prevention: screening and surveillance of persons at average and high risk for colorectal cancer.
    Peterson KA; DiSario JA
    Hematol Oncol Clin North Am; 2002 Aug; 16(4):841-65. PubMed ID: 12418051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectosigmoid polyps as markers of proximal colonic neoplasms: a cost benefit analysis of different diagnostic protocols.
    Arrigoni A; Pennazio M; Rossini FP
    Anticancer Res; 1995; 15(2):563-7. PubMed ID: 7763038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of colon cancer screening.
    Lieberman D
    Am J Gastroenterol; 1991 Dec; 86(12):1789-94. PubMed ID: 1962624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Not requiring a co-pay boosts colorectal screening.
    Harv Mens Health Watch; 2012 Oct; 17(3):1, 8. PubMed ID: 23175866
    [No Abstract]   [Full Text] [Related]  

  • 13. Colon cancer prevention in Italy: cost-effectiveness analysis with CT colonography and endoscopy.
    Hassan C; Zullo A; Laghi A; Reitano I; Taggi F; Cerro P; Iafrate F; Giustini M; Winn S; Morini S
    Dig Liver Dis; 2007 Mar; 39(3):242-50. PubMed ID: 17112797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and the costs of treating colorectal cancer: some preliminary results.
    Tuck J; Walker A; Whynes DK; Pye G; Hardcastle JD; Chamberlain J
    Public Health; 1989 Nov; 103(6):413-9. PubMed ID: 2692062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up in colorectal cancer: cost-effectiveness analysis of established and novel concepts.
    Staib L; Link KH; Beger HG
    Langenbecks Arch Surg; 2000 Oct; 385(6):412-20. PubMed ID: 11127527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of workup strategy on the cost-effectiveness of fecal occult blood screening for colorectal cancer.
    Barry MJ; Mulley AG; Richter JM
    Gastroenterology; 1987 Aug; 93(2):301-10. PubMed ID: 3109993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for gastrointestinal neoplasia: efficacy and cost of two different approaches in a clinical rehabilitation centre.
    Manus B; Brägelmann R; Armbrecht U; Stolte M; Stockbrügger RW
    Eur J Cancer Prev; 1996 Feb; 5(1):49-55. PubMed ID: 8664809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening flexible sigmoidoscopy by primary care physicians. Effectiveness and costs in patients negative for fecal occult blood.
    Rumans MC; Benner KG; Keeffe EB; Custis JM; Lockwood DR; Craner GE
    West J Med; 1986 Jun; 144(6):756-8. PubMed ID: 3088841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of colorectal cancer screening with computed tomography colonography or fecal blood tests.
    Heresbach D; Chauvin P; Grolier J; Josselin JM
    Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1372-9. PubMed ID: 20802341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colonoscopy.
    Rex DK
    Gastrointest Endosc Clin N Am; 2000 Jan; 10(1):135-60, viii. PubMed ID: 10618459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.